ArticleInnovation (Cambridge (Mass.))2026

Design and development of novel EGFR inhibitors spanning all subgroups of EGFR mutations in non-small cell lung cancer.

Caolin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.